Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice
{{output}}
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide and its prognosis is highly heterogeneous, being related not only to tumour burden but also to the severity of underlying chronic liver disease. Moreover, advances in systemic... ...
